Jeffrey S. Parkin

Array ( [id] => 1391319 [patent_doc_number] => 06541208 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Diagnostic method for distinguishing HIV-associated dementia from other forms of dementia' [patent_app_type] => B1 [patent_app_number] => 09/042820 [patent_app_country] => US [patent_app_date] => 1998-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4809 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541208.pdf [firstpage_image] =>[orig_patent_app_number] => 09042820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4378982 [patent_doc_number] => 06261763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion' [patent_app_type] => 1 [patent_app_number] => 8/973601 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 16117 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261763.pdf [firstpage_image] =>[orig_patent_app_number] => 973601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4348100 [patent_doc_number] => 06291157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Antigenically-marked non-infectious retrovirus-like particles' [patent_app_type] => 1 [patent_app_number] => 9/027955 [patent_app_country] => US [patent_app_date] => 1998-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10330 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291157.pdf [firstpage_image] =>[orig_patent_app_number] => 027955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 492178 [patent_doc_number] => 07211260 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-01 [patent_title] => 'Infectious bursitis vaccine' [patent_app_type] => utility [patent_app_number] => 09/355374 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3370 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211260.pdf [firstpage_image] =>[orig_patent_app_number] => 09355374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1541388 [patent_doc_number] => 06372217 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Methods for the treatment of CD7 viral infection with TXU-7-PAP' [patent_app_type] => B1 [patent_app_number] => 09/014028 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19838 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372217.pdf [firstpage_image] =>[orig_patent_app_number] => 09014028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418786 [patent_doc_number] => 06177253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24' [patent_app_type] => 1 [patent_app_number] => 8/894295 [patent_app_country] => US [patent_app_date] => 1998-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 11 [patent_no_of_words] => 15538 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177253.pdf [firstpage_image] =>[orig_patent_app_number] => 894295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375936 [patent_doc_number] => 06261564 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Peptides of human immunodeficiency virus type 1 (HIV-1)' [patent_app_type] => 1 [patent_app_number] => 9/344449 [patent_app_country] => US [patent_app_date] => 1997-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 4116 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261564.pdf [firstpage_image] =>[orig_patent_app_number] => 344449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409332 [patent_doc_number] => 06172190 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Caspase-8h and Caspase-8i-polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/001777 [patent_app_country] => US [patent_app_date] => 1997-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 17643 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172190.pdf [firstpage_image] =>[orig_patent_app_number] => 001777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097189 [patent_doc_number] => 06099848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use' [patent_app_type] => 1 [patent_app_number] => 8/972902 [patent_app_country] => US [patent_app_date] => 1997-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 11 [patent_no_of_words] => 14635 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/099/06099848.pdf [firstpage_image] =>[orig_patent_app_number] => 972902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388744 [patent_doc_number] => 06544787 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation' [patent_app_type] => B1 [patent_app_number] => 08/995049 [patent_app_country] => US [patent_app_date] => 1997-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 13497 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544787.pdf [firstpage_image] =>[orig_patent_app_number] => 08995049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942153 [patent_doc_number] => 05998131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Screening methods for the identification of compounds capable of abrogating BaK-BHRF-1 protein interactions' [patent_app_type] => 1 [patent_app_number] => 8/944530 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 3 [patent_no_of_words] => 7040 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998131.pdf [firstpage_image] =>[orig_patent_app_number] => 944530 [rel_patent_id] =>[rel_patent_doc_number] =>)